|
Mark McDade is Chief Executive Officer of PDL Biopharma. Prior to PDL, he served as CEO of Signature BioScience, Inc. and was previously a co-founder and director of Corixa Corporation, where he served as Chief Operating Officer from September 1994 through December 1998 and as President and Chief Operating Officer from January 1999 until his departure in late 2000. Before Corixa, Mr. McDade was Chief Operating Officer of Boehringer Mannheim.
Therapeutics, and prior to that held several positions at Sandoz Ltd. including business development, product management and general management. Mr. McDade currently serves on the board of directors of Cytokinetics, Inc. He received a B.A. from Dartmouth College and an M.B.A. from Harvard Business School. | 